{"schema_version":"secwatch.filing_event.v1","accession":"0001999480-24-000033","form_type":"8-K","ticker":"ANRO","cik":"0001999480","company_name":"Alto Neuroscience, Inc.","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.335095+00:00","generated_at":"2026-05-31T09:52:40.595405+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Alto Neuroscience Q2 2024 net loss $16.0M; cash $193.6M; Phase 2b MDD topline due Oct 2024","bullets":["Cash, cash equivalents, and restricted cash of $193.6M as of June 30, 2024; expected to fund operations into 2027.","Net loss of $16.0M for Q2 2024 vs $8.7M in Q2 2023; R&D expenses rose to $13.2M from $7.1M.","Completed enrollment of 301 patients in Phase 2b MDD study of ALTO-100; topline data expected in October 2024.","Initiated Phase 2 studies: ALTO-101 in schizophrenia CIAS, ALTO-203 in MDD with anhedonia, ALTO-100 in bipolar depression.","Received $11.7M Wellcome Trust award for ALTO-100 in bipolar depression; added COO Michael Hanley."],"urls":{"canonical":"https://secwatch.observer/filing/0001999480-24-000033","json":"https://secwatch.observer/filing/0001999480-24-000033.json","markdown":"https://secwatch.observer/filing/0001999480-24-000033.md","text":"https://secwatch.observer/filing/0001999480-24-000033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1999480/000199948024000033/0001999480-24-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1999480/000199948024000033/alto-20240813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:52:40.595405+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}